SONM · Sonim Technologies, Inc.

Sonim Technologies pivoted in FY2025 to the DNA X crypto trading platform, acquired December 15, following wind-down of phone and hotspot assets sold post-period in January 2026. This transition drove operating income to -$5.4M, entirely from general and administrative expenses covering DNA X management, legal fees, external audits, and director costs. The Company stopped purchasing parts and inventory by year-end, eliminating significant non-cancelable purchase orders and underscoring the strategic shift away from legacy hardware.

Net income deepened to -$20.7M, yielding diluted EPS of $-28.58, as Sonim incurred losses while building its crypto platform amid market headwinds. Management notes the decrease in cryptocurrency values since October 2025 negatively affected trading volume, contributing to the weak financial results. Operating cash flows consumed -$23.5M, with free cash flow at -$23.7M after limited $214K capex, reflecting investment in platform infrastructure during low-volume conditions.

Looking forward, Sonim anticipates ongoing losses and negative operating cash flows as it develops and grows the DNA X platform, requiring additional funding for planned activities. Management will monitor the platform to handle anticipated 2026 trading volume increases, using prior offering proceeds for business strategy, working capital, and general purposes. This positions Sonim for potential recovery if crypto markets rebound, but underscores near-term funding urgency and execution risks in scaling the platform.